Association of Blood Pressure Lowering Intensity With White Matter Network Integrity in Patients With Cerebral Small Vessel Disease

Background and Objectives Diffusion tensor imaging (DTI) networks integrate damage from a variety of pathologic processes in cerebral small vessel disease (SVD) and may be a sensitive marker to detect treatment effects. We determined whether brain network analysis could detect treatment effects in the PRESERVE trial data set, in which intensive vs standard blood pressure (BP) lowering was compared. The primary end point of DTI had not shown treatment differences. Methods Participants with lacunar stroke were randomized to standard (systolic 130–140 mm Hg) or intensive (systolic ≤ 125 mm Hg) BP lowering and followed for 2 years with MRI at baseline and at 2 years. Graph theory–based metrics were derived from DTI data to produce a measure of network integrity weighted global efficiency and compared with individual MRI markers of DTI, brain volume, and white matter hyperintensities. Results Data were available in 82 subjects: standard n = 40 (mean age 66.3 ± 1.5 years) and intensive n = 42 (mean age 69.6 ± 1.0 years). The mean (SD) systolic BP was reduced by 13(14) and 23(23) mm Hg in the standard and intensive groups, respectively (p < 0.001 between groups). Significant differences in diffusion network metrics were found, with improved network integrity (weighted global efficiency, p = 0.002) seen with intensive BP lowering. In contrast, there were no significant differences in individual MRI markers including DTI histogram metrics, brain volume, or white matter hyperintensities. Discussion Brain network analysis may be a sensitive surrogate marker in trials in SVD. This work suggests that measures of brain network efficiency may be more sensitive to the effects of BP control treatment than conventional DTI metrics. Trial Registration Information The trial is registered with the ISRCTN Registry (ISRCTN37694103; doi.org/10.1186/ISRCTN37694103) and the NIHR Clinical Research Network (CRN 10962; public-odp.nihr.ac.uk/QvAJAXZfc/opendoc.htm?document=crncc_users%5Cfind%20a%20clinical%20research%20study.qvw&lang=en-US&host=QVS%40crn-prod-odp-pu&anonymous=true). Classification of Evidence This study provides Class II evidence that intensive BP lowering in patients with SVD results in improved brain network function when assessed by DTI-based brain network metrics.

[1]  A. Blamire,et al.  PRESERVE: Randomized Trial of Intensive Versus Standard Blood Pressure Control in Small Vessel Disease , 2021, Stroke.

[2]  Guy B. Williams,et al.  Microglial activation and blood–brain barrier permeability in cerebral small vessel disease , 2021, Brain : a journal of neurology.

[3]  J. O'Brien,et al.  In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[4]  D. Norris,et al.  Structural network changes in cerebral small vessel disease , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[5]  Jackson T. Wright,et al.  Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. , 2019, JAMA.

[6]  J. Williamson,et al.  Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial , 2019, JAMA.

[7]  M. Kivimäki,et al.  Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension , 2018, European heart journal.

[8]  R. Morris,et al.  Longitudinal decline in structural networks predicts dementia in cerebral small vessel disease , 2018, Neurology.

[9]  J. Newburger,et al.  Graph theory analysis of cortical thickness networks in adolescents with d‐transposition of the great arteries , 2018, Brain and behavior.

[10]  J. O'Brien,et al.  Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies , 2017, Clinical science.

[11]  H. Markus,et al.  Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  David C. Anderson,et al.  Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial , 2014, The Lancet Neurology.

[13]  A. W. Chung,et al.  Structural network efficiency is associated with cognitive impairment in small-vessel disease , 2014, Neurology.

[14]  J. Gee,et al.  The Insight ToolKit image registration framework , 2014, Front. Neuroinform..

[15]  R. Conwit,et al.  Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial , 2013, The Lancet.

[16]  V. Hachinski,et al.  Antihypertensive treatment can prevent stroke and cognitive decline , 2012, Nature Reviews Neurology.

[17]  Alan Connelly,et al.  MRtrix: Diffusion tractography in crossing fiber regions , 2012, Int. J. Imaging Syst. Technol..

[18]  L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[19]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[20]  Jan Stam,et al.  Dynamic Cerebral Autoregulation in Acute Lacunar and Middle Cerebral Artery Territory Ischemic Stroke , 2005, Stroke.

[21]  L. Kalra,et al.  Blood Pressure Reduction for Vascular Risk: Is There a Price To Be Paid? , 2005, Stroke.

[22]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[23]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[24]  P. Basser,et al.  In vivo fiber tractography using DT‐MRI data , 2000, Magnetic resonance in medicine.

[25]  A Hofman,et al.  Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly , 1999, Neurology.

[26]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[27]  C. Escobar Cervantes,et al.  [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.

[28]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[29]  Skipper Seabold,et al.  Statsmodels: Econometric and Statistical Modeling with Python , 2010, SciPy.